(Q48639806)

13 February 2018

title

Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice (English)

1 reference

13 February 2018

author

Thomas N. Seyfried

4

1 reference

13 February 2018

author name string

J R Arthur

1

1 reference

13 February 2018

J P Lee

2

1 reference

13 February 2018

E Y Snyder

3

1 reference

13 February 2018

publication date

25 February 2012

1 reference

13 February 2018

published in

Neurochemical Research

1 reference

13 February 2018

volume

37

1 reference

13 February 2018

issue

6

1 reference

13 February 2018

page(s)

1335-1343

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1007/s11064-012-0718-0

exact match

0 references

cites work

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB-/- mouse model of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Substrate reduction therapy in mouse models of the glycosphingolipidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

New developments in treating glycosphingolipid storage diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Influence of caloric restriction on motor behavior, longevity, and brain lipid composition in Sandhoff disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Substrate reduction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Glucosylceramide synthase and glycosphingolipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Gangliosides in developing mouse brain myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Cellular localization of gangliosides in the developing mouse cerebellum: analysis using the weaver mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Ganglioside abnormalities associated with failed neural differentiation in a T-locus mutant mouse embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Developmental changes in ganglioside composition and synthesis in embryonic rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Early Diagnosis and Prevention of Genetic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Inheritance of lysosomal acid beta-galactosidase activity and gangliosides in crosses of DBA/2J and knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Expression profile of an operationally-defined neural stem cell clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Multipotent neural cell lines can engraft and participate in development of mouse cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

"Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Gene therapy: can neural stem cells deliver?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Cellular therapy for childhood neurodegenerative disease. Part I: rationale and preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Cellular therapy for childhood neurodegenerative disease. Part II: clinical trial design and implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Stem cells in human neurodegenerative disorders--time for clinical translation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Translation of stem cell therapy for neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0718-0

Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method

21 January 2018

1 reference

12 December 2020

Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice

1 reference

12 December 2020

Potential of neural "stem-like" cells for gene therapy and repair of the degenerating central nervous system

1 reference

12 December 2020

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo

1 reference

12 December 2020

Substrate deprivation therapy in juvenile Sandhoff disease

1 reference

12 December 2020

A simple method for the isolation and purification of total lipides from animal tissues

1 reference

12 December 2020

Isolation and characterization of human liver hematoside

1 reference

12 December 2020

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis

1 reference

12 December 2020

Analysis of brain lipids by high performance thin-layer chromatography and densitometry.

1 reference

12 December 2020

10.1007/S11064-012-0718-0

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018